Too Old to Operate9d
Adherence Patterns for Oral Semaglutide vs DPP-4 Inhibitors in Type 2 Diabetes
The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...
Endocrinology Advisor2d
ASH: GLP-1 RA Use Tied to Lower Rate of Venous Thromboembolism in Diabetes
For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE).
healthday on MSN11d
SGLT-2 Inhibitors Beneficial for Patients With Nephrolithiasis
For patients with nephrolithiasis, sodium-glucose cotransporter-2 (SGLT-2) inhibitor use is associated with a reducti ...
Renal & Urology News8d
SGLT2 Inhibitors Might Lower Stone Risk Better Than Other Type 2 Diabetes Drugs
SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...
GLP-1 RA use tied to lower rate of venous thromboembolism in diabetes
For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...